Cochrane Renal Group

 Back
autoid 90
crg_id CRG010600027
titleoftrial Influence of water soluble vitamin supplementation on morbidity and mortality of patients with end-stage renal disease
acronymnoftrial
website http://
identificationno
leadprefix Prof
leadsurname Luley
leadgivennames Claus
leadposition Head of Institute
leaddepartment Institute of Clinical Chemistry
leadorganisation University Hospital Magdeburg
leadaddress Leipziger Strasse 44, 39120 Magdeburg, Germany
leademail claus.luley@medizin.uni-magdeburg.de
leadphone +49-391-6713900
leadfax +49-391-6713902
leadsuffix
contactprefix Dr
contactsurname Domroese
contactgivennames Ute
contactposition assistant medical director
contactdepartment Internal Medicine, Division of Nephrology
contactorganisation University Hospital Magdeburg
contactaddress Leipziger Strasse 44, 39120 Magdeburg, Germany
contactemail ute.domroese@kfh-dialyse.de
contactphone +49-391-288090
contactfax +49-391-2880925
funding other
otherfunding Industry (production of vitamin preparation, personal & laboratory costs) and public funding (personnel and laboratory tests)
fundingnameofsponsors
ethicsapproval yes
studytype randomised
studytype_other
groupassignment parallel
blinding_patients yes
blinding_investigators yes
blinding_outcomes yes
blinding_analysts yes
proposedstart 07/2002
actualstart 07/2002
proposedcompletiondate 07/2006
actualcompletiondate 12/2007
multi_center_study yes
numberofcentres 31_35
multi_national_study no
countrycentres Germany
researchquestion Does watersoluble vitamin supplementation reduce morbidity and mortality in patients with end-stage renal disease?
study_status_recruitment closed
study_status_recruitment_follow closed
healthcarecondition end-stage renal disease
intervention1 watersoluble vitamins (difference in folic acid, vitamin B6, vitamin B12)
intervention2
intervention3
intervention4
participants_gender both
participants_other adults
age 20 - 80 years
totalrecruitment 620
inclusion - age 20-80 years
- end-stage renal disease
- treatment with hemodialysis
exclusion - addiction to drugs or alcohol
- legal incapacity
- missing consent
- acute cardiovascular events (6 weeks before
enrollment)
- pregnancy and lactation
- intake of folic acid (other than treatment of
acute deficiency)
primaryoutcomes total mortality
secondaryoutcomes mortality and morbidity due to cardiovascular disease
- cardiac infarction
- unstable angina pectoris
- bypass surgery
- sudden cardiac death
- stroke
- peripheral vascular disease
- thrombosis
- pulmonary embolism
reference Heinz J, Domrose U, Luley C, Westphal S, Kropf S, Neumann KH, et al. Influence of a supplementation with vitamins on cardiovascular morbidity and mortality in patients with end-stage renal disease: design and baseline data of a randomized clinical trial. Clinical Nephrology 2009 Mar;71(3):363-5.
Heinz J, Dierkes J, Domrose U, Neumann KH, Luley C. Influence of a supplementation with vitamins on morbidity and mortality of ESRD patients - a multi-center randomly designed double blinded intervention trial; Prismavit - prospective intervention study from magdeburg with vitamins.
XIV Lipid Meeting 2003, Leipzig (Germany), Poster session, Abstract book p.89

Heinz J, Dierkes J, Westphal S, Domr?se U, Neumann KH, Luley C. Lipid lowering therapy with statins in ESRD patients in Germany - baseline data from an ongoing prospective study with vitamins. 1st German Atherosclerosis Symposium 2004, Leipzig (Germany), poster session, Abstract book p. 26

Heinz J, Dierkes J, Martens-Lobenhoffer J, Bode-B?ger SM, Domr?se U, Neumann KH, Luley C. Asymmetric dimethylarginine plasma concentrations in patients with end-stage renal disease and other risk factors. Vascular NO: From Bench to Bedside. An International Symposium 2004, Hannover (Germany), Poster session, Abstract book